vax125
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00730457)
Timeline
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vax125
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00966238 | Phase 2 | Sep 1, 2009 | VaxInnate Corporation |
| NCT00730457 | Phase 1 | Jul 1, 2008 | University of Rochester, VaxInnate Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VaxInnate Corporation | For profit | 2 | 2 | 2 | 2008 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1